Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-24T01:29:35.882Z Has data issue: false hasContentIssue false
  • English
  • Français

The effect of acute feeding of carnitine, acetyl carnitine and propionyl carnitine on basal and A23187-stimulated eicosanoid release from rat carrageenan-elicited peritoneal macrophages

Published online by Cambridge University Press:  09 March 2007

G. R. Elliott ,
A. P. M. Lauwen  and
I. L. Bonta
G. R. Elliott
Affiliation:
Pharmacology Department, Erasmus University Rotterdam, Postbox 1738, 3000DR Rotterdam, The Netherlands
A. P. M. Lauwen
Affiliation:
Pharmacology Department, Erasmus University Rotterdam, Postbox 1738, 3000DR Rotterdam, The Netherlands
I. L. Bonta
Affiliation:
Pharmacology Department, Erasmus University Rotterdam, Postbox 1738, 3000DR Rotterdam, The Netherlands
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Little is known about the ability of carnitine to modulate cell functions. As carnitine plays an important role in lipid metabolism we investigated the acute effect of L-carnitine, L-acetyl carnitine and L-propionyl carnitine (300 mg/kg per d; 4 d) on the basal and calcium-ionophore (A23187)-stimulated release of arachidonic acid metabolites from rat carrageenan-elicited peritoneal macrophages. A decrease in the number of peritoneal carrageenan-elicited macrophages was observed after feeding all three compounds. The basal release of prostaglandin E2, 6 keto-prostaglandin F1α and leukotriene B4 was stimulated by all treatments. In contrast, thromboxane B2 production was diminished by feeding carnitine and acetyl carnitine. A23187-stimulated synthesis of 6 keto-prostaglandin F1α and leukotriene B4 was further enhanced by all three compounds. Acetyl carnitine and propionyl carnitine also enhanced thromboxane B2 synthesis. However, no effects on prostaglandin E2 formation were detected. The 6 keto-prostaglandin F1α: thromboxane B2 ratio, calculated from the basal and A23187-stimulated values, was increased by carnitine treatment. In the presence of A23187 there was also an increase in the 6 keto-prostaglandin F1α: leukotriene B4 ratio. We conclude that carnitine, and possibly some of its derivatives, could modify the macrophage component of an inflammation in vivo.

Keywords

Carnitine compoundsPeritoneal macrophagesArachidonic acid metabolitesRat
Type
Diet and Lipid Metabolism
Information
British Journal of Nutrition , Volume 64 , Issue 2 , September 1990 , pp. 497 - 503
Copyright
Copyright © The Nutrition Society 1990

References

Baud, L., Perez, P., Denis, M. & Ardaillou, R. (1987). Modulation of fibroblast growth by sulfidopeptide leukotrienes: effect of indomethacin. Journal of Immunology 138, 1190–1195.Google Scholar
Bremer, J. (1983). Carnitine: metabolism and functions. Physiological Review 63, 1420–1480.CrossRefGoogle ScholarPubMed
Christopherson, B. O. & Norseth, J. (1981). Arachidonic acid synthesis studied in isolated liver cells. Effects of (-)-carnitine and of (+)-decanoylcarnitine. FEBS Letters 133, 201204.CrossRefGoogle Scholar
De Simone, C., Ferrari, M., Lozzi, A., Meli, D., Ricca, D. & Sorice, F. (1982). Vitamins and immunity. II. influence of l-carnitine on the immune system. Acta Vitconinologica et Enzymologica 4, 135–140.Google ScholarPubMed
Ford-Hutchinson, A. W., Bray, M. A., Doig, D. V., Shipley, M. E. & Smith, M. J. H. (1980) Leukotriene B4, a potent chemotactic and aggregating substance released by polymorphonuclear leucocytes, Nature 286, 264–265.CrossRefGoogle Scholar
Gemsa, D., Leser, H. G., Seitz, M., Debatin, M., Barlin, E., Deimann, W. & Kramer, W. (1982). Cells in inflammation: the role of macrophages in inflammation. In Agents and Actions Supplements, vol. 11, pp. 93–114 [Parnham, M. J. and Winkelmann, J., editors]. Basel, Boston and Stuttgart: Birkhauser-Verlag.Google Scholar
Gryglewski, R. J., Dembinska–Kiec, A., Zmuda, A. & Gryglewska, T. (1978). Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. Atherosclerosis 31, 385–394.Google Scholar
Humes, J. L., Burger, S., Galavage, M., Kuehl, F. A., Wightman, P. D., Dahlgren, M., Davies, P. & Bonney, R. J. (1982). Evidence for two sources of archidonic acid for oxidative metabolism by mouse peritoneal macrophages. Journal of Biological Chemistry 257, 1591–1594.Google Scholar
Kunkel, S. L. & Chensue, S. W. (1985). Archidonic acid metabolites regulate interleukin-1 production. Biochemical and Biophysical Research Communications 128, 892–897.Google Scholar
Levine, R. P. (1982) How is the level of free arachidonic acid controlled in mammalian cells? Biochemical Journal 204, 3–16.Google Scholar
Mead, C. J., Harvey, J., Boot, J. H., Turner, G. A., Bateman, P. E. & Osborne, D. J. (1984). Hexa-chlorocyclohexane stimulation of macrophage phospholipid hydrolysis and leukotriene production. Biochemical Pharmacology 33, 289–293.Google Scholar
Ophir, R., Ben-Efraim, S. & Bonta, I. (1987). Leukotriene D4 and indomethacin enhance additively the macrophage cytostatic activity in vitro towards MOPC-315 tumour cells. International Journal of Tissue Reactions IX, 189–194.Google Scholar
Schenkelaars, E. J. & Bonta, I. L. (1986). Cyclooxygenase inhibitors promote the leukotriene C4 induced release of β-glucuronidase from rat peritoneal macrophages: prostaglandin E2 suppresses. International Journal of Immunopharmacology 8, 305–311.Google Scholar
Schinetti, M. L. & Mazzini, A. (1986). Effects of l-carnitine on human neutrophil activity. International Journal of Tissue Reactions VIII, 199–203.Google Scholar
Smith, R. L. & Weidemann, M. J. (1980). Reactive oxygen production associated with arachidonic acid metabolism by peritoneal macrophages. Biochemical and Biophysical Research Communications 97, 973–980.Google Scholar
Vargaftig, B. B., Chignard, M., Mencia-Huerta, J. M., Arnoux, B. & Benveniste, J. (1981). Pharmacology of arachidonic acid metabolites and of platelet-activating factor (PAF-acether). In Platelets in Biology and Pathology, pp. 373–406 [Gordon, J., editor]. Amsterdam: Elsevier/North-Holland Biomedical Press.Google Scholar
Wroblewsky, F. & LaDue, J. S. (1955). Lactic dehydrogenase activity in blood. Proceedings of the Society for Experimental Biology and Medicine 20, 210–213.Google Scholar
Zijlstra, F. J. & Vincent, J. E. (1984). Determination of leukotrienes and prostaglandins in [14C]arachidonic acid labelled human lung tissue by high-performance liquid chromatography and radioimmunoassay. Journal of Chromatography 311, 39–50.Google Scholar